Table 4.
Type of nanostructure for confirmed and likely nanomedicine applications and products, by developmental status.
| Nanocomponent | Investigational | Commercial | ||||
|---|---|---|---|---|---|---|
| Therapeutic | Device | Total | Therapeutic | Device | Total | |
| Hard Nanoparticle | 3 | 12 | 15 | 0 | 28 | 28 |
| Nanodispersion | 5 | 0 | 5 | 1 | 1 | 2 |
| Polymeric Nanoparticle | 23 | 0 | 23 | 9 | 0 | 9 |
| Protein Nanoparticle | 4 | 0 | 4 | 2 | 0 | 2 |
| Liposome | 53 | 0 | 53 | 7 | 1 | 8 |
| Emulsion | 18 | 1 | 19 | 9 | 0 | 9 |
| Micelle | 8 | 0 | 8 | 3 | 1 | 4 |
| Dendrimer / Fleximer | 2 | 2 | 4 | 0 | 3 | 3 |
| Virosome | 6 | 0 | 6 | 2 | 0 | 2 |
| Nanocomposite | 0 | 0 | 0 | 0 | 18 | 18 |
| Nanoparticle Coating | 0 | 2 | 2 | 0 | 6 | 6 |
| Nanoporous Material | 0 | 3 | 3 | 0 | 2 | 2 |
| Nanopatterned | 0 | 2 | 2 | 0 | 2 | 2 |
| Quantum Dot | 0 | 1 | 1 | 0 | 4 | 4 |
| Fullerene | 0 | 1 | 1 | 0 | 0 | 0 |
| Hydrogel | 0 | 0 | 0 | 0 | 1 | 1 |
| Carbon Nanotube | 0 | 1 | 1 | 0 | 0 | 0 |
| Totals: | 122 | 25 | 147 | 33 | 67 | 100 |